Aradigm has announced that the United States Patent and Trademark Office has issued an additional patent covering several formulations of ciprofloxacin, including the company's lead product, Pulmaquin dual release ciprofloxacin for inhalation. The patent (US Patent No. 8,119,156) will provide exclusivity for Pulmaquin until October 22, 2028. The company, which … [Read more...] about US Patent Office issues new patent for Aradigm’s Pulmaquin
News
New OINDP testing consultancy launched
Inhalation testing specialist Frank Chambers has launched a new analytical consultancy specializing in OINDP testing called Inhalytic. Chambers, whose most recent position was as Senior Scientist at AstraZeneca, where he performed analytical research on inhaler products, is a member of the EPAG Impactor sub-team and has published numerous scientific articles. … [Read more...] about New OINDP testing consultancy launched
FDA to review inhaled caffeine product
According to the Associated Press, the FDA will investigate the safety of Aeroshot inhalable caffeine and whether the product can be considered a dietary supplement as the manufacturer claims or if it is subject to regulation as a drug. AeroShot is manufactured by Breathable Foods, co-founded by Harvard professor David Edwards. The report says that FDA Commissioner … [Read more...] about FDA to review inhaled caffeine product
Aerogen authorized to market nebulizers in China
Irish nebulizer manufacturer Aerogen has received authorization from the Chinese State Food and Drug Administration (SFDA) to market its Aeroneb Pro and Aeroneb Go vibrating mesh nebulizers in China. The company expects to begin selling the products in the country by March 2012, with distributed handled by Gaelmed. Aerogen currently markets products in 65 countries. … [Read more...] about Aerogen authorized to market nebulizers in China
Alexza offers common stock and warrants
Alexza Pharmaceuticals, which is developing a number of inhaled drugs using its proprietary Staccato inhaler, will offer 44,000,000 shares of common stock and 44,000,000 warrants to purchase common stock at $0.50 per share for a total offer of $22 million. One warrant to purchase a common share will be sold with each common share. According to the company, the money … [Read more...] about Alexza offers common stock and warrants
Critical Pharmaceuticals and U. of Nottingham team on osteoporosis nasal spray
Critical Pharmaceuticals and the University of Nottingham have announced a new partnership for development of a "nano-enabled" intranasal formulation of teriparatide for the treatment of osteoporosis. Funding for the £545,000 collaboration is coming from the Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC). “We are … [Read more...] about Critical Pharmaceuticals and U. of Nottingham team on osteoporosis nasal spray
Acorda acquires Neuronex, diazepam nasal spray program
US pharmaceutical company Acorda Therapeutics President and CEO Ron Cohen has announced that the company is "excited" about an agreement with Neuronex, Inc. that will allow Acorda to acquire the company and its diazepam nasal spray program. Acorda has made an upfront payment of $2 million to acquire Neuronex, a North Carolina-based pharmaceutical company, plus … [Read more...] about Acorda acquires Neuronex, diazepam nasal spray program
Aptar introduces electronic dose counter and lockout for nasal sprays
Aptar Pharma is introducing two new eDevices, an electronic dose counter and an electronic lockout mechanism for nasal and sub-lingual spray pumps. The new devices can help products meet regulatory requirements for the delivery of controlled substances and are meant to help improve patient compliance. According to the company, the e-Dose Counter features a large, … [Read more...] about Aptar introduces electronic dose counter and lockout for nasal sprays
E-cigarette explodes in user’s mouth
According to news reports, a Florida man lost his teeth and part of his tongue when the battery in an e-cigarette exploded in his mouth on February 14. The explosion also started a fire in the man's home. Officials said that they were unable to determine the manufacturer of the e-cigarette. In October 2010, the US Court of Appeals ruled that the FDA has no … [Read more...] about E-cigarette explodes in user’s mouth
Mylan says it will challenge verdict in Sunovion Xopenex patent infringement suit
A jury has awarded $18 million to Sunovion Pharmaceuticals after finding that Mylan willfully infringed on patents for Xopenex levalbuterol hydrochloride inhalation solution when its subsidiary Dey marketed generic versions of the product. The trial took place in the US District Court for the District of Delaware. The patents involved are US patents numbers … [Read more...] about Mylan says it will challenge verdict in Sunovion Xopenex patent infringement suit